{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:35Z","timestamp":1786995035432,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.niox.2022.07.007","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T19:57:01Z","timestamp":1660420621000},"page":"12-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: Structure-activity relationship and mechanism of action"],"prefix":"10.1016","volume":"128","author":[{"given":"Karim","family":"Zuhra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barkha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Panagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Myrianthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Schneiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mikros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Majtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.niox.2022.07.007_bib1","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1039\/C7FO00611J","article-title":"Healthy properties of green and white teas: an update","volume":"8","author":"Pastoriza","year":"2017","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.niox.2022.07.007_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00003-007-0250-3","article-title":"Characterisation of white tea - comparison to green and black tea","volume":"2","author":"Hilal","year":"2007","journal-title":"J. Consum. Prot. Food Saf."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/molecules26010085","article-title":"Health benefits and chemical composition of matcha green tea: a review","volume":"26","author":"Kochman","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.niox.2022.07.007_bib4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0955-2863(01)00155-3","article-title":"A review of latest research findings on the health promotion properties of tea","volume":"12","author":"Dufresne","year":"2001","journal-title":"J. Nutr. Biochem."},{"issue":"24","key":"10.1016\/j.niox.2022.07.007_bib5","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.3390\/ijms20246196","article-title":"Health functions and related molecular mechanisms of tea components: an update review","volume":"20","author":"Tang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2022.07.007_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132135","article-title":"Epigallocatechin 3-gallate: from green tea to cancer therapeutics","volume":"379","author":"Alam","year":"2022","journal-title":"Food Chem."},{"issue":"12","key":"10.1016\/j.niox.2022.07.007_bib7","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/aps.2011.139","article-title":"Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro","volume":"33","author":"Zhou","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.niox.2022.07.007_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cbi.2010.03.036","article-title":"(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF\/VEGFR axis in human colorectal cancer cells","volume":"185","author":"Shimizu","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib10","first-page":"69","article-title":"EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells","volume":"5","author":"Shimizu","year":"2005","journal-title":"J. Exp. Therapeut. Oncol."},{"issue":"12","key":"10.1016\/j.niox.2022.07.007_bib11","first-page":"5325","article-title":"Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells","volume":"33","author":"Moseley","year":"2013","journal-title":"Anticancer Res."},{"issue":"Pt 1","key":"10.1016\/j.niox.2022.07.007_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2022.07.007_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in Down syndrome","volume":"10","author":"Duchon","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.niox.2022.07.007_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mnfr.201300325","article-title":"Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans","volume":"58","author":"De la Torre","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"issue":"6","key":"10.1016\/j.niox.2022.07.007_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbadis.2016.03.003","article-title":"The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model","volume":"1862","author":"Valenti","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib16","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1038\/s41598-019-40328-9","article-title":"Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models","volume":"9","author":"Souchet","year":"2019","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.niox.2022.07.007_bib17","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1073\/pnas.1921314117","article-title":"Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability","volume":"117","author":"Alemany-Gonz\u00e1lez","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72625-z","article-title":"Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment","volume":"10","author":"De Toma","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67133-z","article-title":"Evaluation of the therapeutic potential of epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice","volume":"10","author":"Goodlett","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.niox.2022.07.007_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264254","article-title":"Increased dosage and treatment time of epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models","volume":"17","author":"Jamal","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.niox.2022.07.007_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"TESDAD study group, Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"De la Torre","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.niox.2022.07.007_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ctim.2019.07.002","article-title":"Usage of and attitudes about green tea extract and epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndrome, Complement","volume":"45","author":"Long","year":"2019","journal-title":"Ther. Med."},{"issue":"4","key":"10.1016\/j.niox.2022.07.007_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.clnu.2019.05.028","article-title":"Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: implications for clinical management","volume":"39","author":"Xicota","year":"2020","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.niox.2022.07.007_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/antiox10030469","article-title":"Epigallocatechin-3-gallate plus omega-3 restores the mitochondrial complex I and F(0)F(1)-ATP synthase activities in PBMCs of young children with Down syndrome: a pilot study of safety and efficacy","volume":"10","author":"Scala","year":"2021","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.niox.2022.07.007_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/biom10050697","article-title":"Cystathionine-beta-synthase: molecular regulation and pharmacological inhibition","volume":"10","author":"Zuhra","year":"2020","journal-title":"Biomolecules"},{"issue":"30","key":"10.1016\/j.niox.2022.07.007_bib26","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2022.07.007_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.niox.2014.03.001","article-title":"Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-beta-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro","volume":"41","author":"Modis","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2022.07.007_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2119\/molmed.2016.00102","article-title":"Cystathionine-beta-synthase inhibition for colon cancer: enhancement of the efficacy of aminooxyacetic acid via the prodrug approach","volume":"22","author":"Chao","year":"2016","journal-title":"J. Mol. Med."},{"issue":"38","key":"10.1016\/j.niox.2022.07.007_bib29","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.1911895116","article-title":"Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome","volume":"116","author":"Panagaki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2022.07.007_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114267","article-title":"Mechanism of cystathionine-beta-synthase inhibition by disulfiram: the role of bis(N,N-diethyldithiocarbamate)-copper(II)","volume":"182","author":"Zuhra","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.niox.2022.07.007_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105290","article-title":"Domain organization, catalysis and regulation of eukaryotic cystathionine beta-synthases","volume":"9","author":"Majtan","year":"2014","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.niox.2022.07.007_bib32","doi-asserted-by":"crossref","first-page":"E3790","DOI":"10.1073\/pnas.1313683110","article-title":"Structural basis of regulation and oligomerization of human cystathionine beta-synthase, the central enzyme of transsulfuration","volume":"110","author":"Ereno-Orbea","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.abb.2007.11.006","article-title":"Purification and characterization of the wild type and truncated human cystathionine beta-synthase enzymes expressed in E. coli","volume":"470","author":"Frank","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.niox.2022.07.007_bib34","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1074\/jbc.M805459200","article-title":"Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H2S","volume":"284","author":"Sun","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.niox.2022.07.007_bib35","doi-asserted-by":"crossref","first-page":"20002","DOI":"10.1074\/jbc.M113.466177","article-title":"Structure and kinetic analysis of H2S production by human mercaptopyruvate sulfurtransferase","volume":"288","author":"Yadav","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"Pt A","key":"10.1016\/j.niox.2022.07.007_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2016.08.016","volume":"113","author":"Druzhyna","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.niox.2022.07.007_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/bi026681n","article-title":"Kinetics of the yeast cystathionine beta-synthase forward and reverse reactions: continuous assays and the equilibrium constant for the reaction","volume":"42","author":"Aitken","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.niox.2022.07.007_bib38","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/j.csbj.2021.05.052","article-title":"Structural insight into the unique conformation of cystathionine beta-synthase from Toxoplasma gondii","volume":"19","author":"Fernandez-Rodriguez","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"17","key":"10.1016\/j.niox.2022.07.007_bib39","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1002\/anie.201300841","article-title":"Identification of cystathionine beta-synthase inhibitors using a hydrogen sulfide selective probe","volume":"52","author":"Thorson","year":"2013","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"8","key":"10.1016\/j.niox.2022.07.007_bib40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/cells8080828","article-title":"N-acetylcysteine serves as substrate of 3-mercaptopyruvate sulfurtransferase and stimulates sulfide metabolism in colon cancer cells","volume":"8","author":"Zuhra","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.niox.2022.07.007_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00018-022-04479-9","article-title":"H2S biogenesis by cystathionine beta-synthase: mechanism of inhibition by aminooxyacetic acid and unexpected role of serine","volume":"79","author":"Petrosino","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.niox.2022.07.007_bib42","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/bi9826052","article-title":"Characterization of the heme and pyridoxal phosphate cofactors of human cystathionine beta-synthase reveals nonequivalent active sites","volume":"38","author":"Taoka","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.niox.2022.07.007_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s42535-022-00437-9","article-title":"Binding of sikokianin C and related C-3\/C-3\u2033-biflavanones to cystathionine \u03b2-synthase. A molecular docking study","author":"Vergoten","year":"2022","journal-title":"Vegetos"},{"issue":"17","key":"10.1016\/j.niox.2022.07.007_bib44","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1021\/ja050974x","article-title":"Site-specific binding of quinones to proteins through thiol addition and addition-elimination reactions","volume":"127","author":"Li","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.niox.2022.07.007_bib45","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddy447","article-title":"CBS overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a","volume":"28","author":"Marechal","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.niox.2022.07.007_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102233","article-title":"Overproduction of hydrogen sulfide, generated by cystathionine beta-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of Down syndrome","volume":"51","author":"Panagaki","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20120731","article-title":"Human cystathionine beta-synthase (CBS) contains two classes of binding sites for S-adenosylmethionine (SAM): complex regulation of CBS activity and stability by SAM","volume":"449","author":"Pey","year":"2013","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.niox.2022.07.007_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1039\/C6MD00493H","article-title":"Discovery of selective cystathionine beta-synthase inhibitors by high-throughput screening with a fluorescent thiol probe","volume":"8","author":"Niu","year":"2017","journal-title":"MedChemComm"},{"issue":"4","key":"10.1016\/j.niox.2022.07.007_bib49","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bph.12171","article-title":"Selectivity of commonly used pharmacological inhibitors for cystathionine beta synthase (CBS) and cystathionine gamma lyase (CSE)","volume":"169","author":"Asimakopoulou","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.niox.2022.07.007_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-4165(01)00230-6","article-title":"Kinetic analysis and mechanistic aspects of autoxidation of catechins","volume":"1569","author":"Mochizuki","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.niox.2022.07.007_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101731","article-title":"Green tea polyphenolic antioxidants oxidize hydrogen sulfide to thiosulfate and polysulfides: a possible new mechanism underpinning their biological action","volume":"37","author":"Olson","year":"2020","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.niox.2022.07.007_bib52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.freeradbiomed.2008.07.023","article-title":"Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation","volume":"45","author":"Ishii","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"22","key":"10.1016\/j.niox.2022.07.007_bib53","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1021\/acs.biochem.8b00092","article-title":"Crystal structures of cystathionine beta-synthase from Saccharomyces cerevisiae: one enzymatic step at a time","volume":"57","author":"Tu","year":"2018","journal-title":"Biochemistry"},{"issue":"6058","key":"10.1016\/j.niox.2022.07.007_bib54","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1209855","article-title":"H2S: a universal defense against antibiotics in bacteria","volume":"334","author":"Shatalin","year":"2011","journal-title":"Science"},{"issue":"6547","key":"10.1016\/j.niox.2022.07.007_bib55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.abd8377","article-title":"Inhibitors of bacterial H2S biogenesis targeting antibiotic resistance and tolerance","volume":"372","author":"Shatalin","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.niox.2022.07.007_bib56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine beta-synthetase\/hydrogen sulfide inhibition in cancer, Antioxid","volume":"22","author":"Hellmich","year":"2015","journal-title":"Redox Signal"},{"issue":"15","key":"10.1016\/j.niox.2022.07.007_bib57","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/febs.15214","article-title":"The re-emerging pathophysiological role of the cystathionine-beta-synthase - hydrogen sulfide system in Down syndrome","volume":"287","author":"Szabo","year":"2020","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.niox.2022.07.007_bib58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.niox.2022.07.007_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/cells10020220","article-title":"Hydrogen sulfide, an endogenous stimulator of mitochondrial function in cancer cells","volume":"10","author":"Szabo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.niox.2022.07.007_bib60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bcp.2017.10.011","article-title":"Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation","volume":"149","author":"Ol\u00e1h","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.niox.2022.07.007_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jare.2020.07.006","article-title":"Targeting hydrogen sulphide signaling in breast cancer","volume":"27","author":"Youness","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.niox.2022.07.007_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105393","article-title":"Pharmacological induction of mesenchymal-epithelial transition via inhibition of H2S biosynthesis and consequent suppression of ACLY activity in colon cancer cells","volume":"165","author":"Ascen\u00e7\u00e3o","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.niox.2022.07.007_bib63","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/biom11081073","article-title":"Efficacy of novel aminooxyacetic acid prodrugs in colon cancer models: towards clinical translation of the cystathionine \u03b2-synthase inhibition concept","volume":"11","author":"Hellmich","year":"2021","journal-title":"Biomolecules"},{"issue":"45","key":"10.1016\/j.niox.2022.07.007_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100050118","article-title":"Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation","volume":"118","author":"Erdelyi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2022.07.007_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102331","article-title":"Emerging roles of cystathionine \u03b2-synthase in various forms of cancer","volume":"53","author":"Ascen\u00e7\u00e3o","year":"2022","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.niox.2022.07.007_bib66","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.21873\/anticanres.12980","article-title":"Epigallocatechin-3-gallate enhances radiation sensitivity in colorectal cancer cells through Nrf2 activation and autophagy","volume":"38","author":"Enkhbat","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.niox.2022.07.007_bib67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neubiorev.2016.10.023","article-title":"Plant polyphenols as natural drugs for the management of Down syndrome and related disorders","volume":"71","author":"Vacca","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.niox.2022.07.007_bib68","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/nu13072232","article-title":"Therapeutic effects of catechins in less common neurological and neurodegenerative disorders","volume":"13","author":"Sebastiani","year":"2021","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.niox.2022.07.007_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007540","article-title":"DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase","volume":"4","author":"Noll","year":"2009","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.niox.2022.07.007_bib70","first-page":"1579","article-title":"Determination of human plasma protein binding of EGCG by ultrafiltration","volume":"43","author":"Wang","year":"2008","journal-title":"J. Chin. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.niox.2022.07.007_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153002","article-title":"Oxidative deamination of serum albumins by (-)-epigallocatechin-3-O-gallate: a potential mechanism for the formation of innate antigens by antioxidants","volume":"11","author":"Hatasa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2022.07.007_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6154170","article-title":"Protein binding characteristics of the principal green tea catechins: a QCM study comparing crude extract to pure EGCG","volume":"2019","author":"Ali","year":"2019","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.niox.2022.07.007_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14189","article-title":"Epigallocatechin gallate: phytochemistry, bioavailability, utilization challenges, and strategies","author":"Mehmood","year":"2022","journal-title":"J. Food Biochem"},{"issue":"10 Pt 1","key":"10.1016\/j.niox.2022.07.007_bib74","first-page":"1025","article-title":"Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"27","key":"10.1016\/j.niox.2022.07.007_bib75","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1021\/acs.jafc.2c02150","article-title":"4\u2033-sulfation is the major metabolic pathway of epigallocatechin-3-gallate in humans: characterization of metabolites, enzymatic analysis, and pharmacokinetic profiling","volume":"70","author":"Hayashi","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.niox.2022.07.007_bib76","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/molecules23061295","article-title":"In vitro and in silico studies of the molecular interactions of epigallocatechin-3-O-gallate (EGCG) with proteins that explain the health benefits of green tea","volume":"23","author":"Saeki","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.niox.2022.07.007_bib77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/molecules25030467","article-title":"Preclinical pharmacological activities of epigallocatechin-3-gallate in signaling pathways: an update on cancer","volume":"25","author":"Sharifi-Rad","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.niox.2022.07.007_bib78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semcancer.2020.05.011","article-title":"Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement","volume":"80","author":"Aggarwal","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"26","key":"10.1016\/j.niox.2022.07.007_bib79","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1021\/acs.jafc.2c02527","article-title":"Redox and other biological activities of tea catechins that may affect health: mechanisms and unresolved issues","volume":"70","author":"Yang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.niox.2022.07.007_bib80","first-page":"1","article-title":"Chemico-biological aspects of (-)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: current status and future prospects","author":"Sahadevan","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.niox.2022.07.007_bib81","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14189","article-title":"Epigallocatechin gallate: phytochemistry, bioavailability, utilization challenges, and strategies","author":"Mehmood","year":"2022","journal-title":"J. Food Biochem."},{"issue":"13","key":"10.1016\/j.niox.2022.07.007_bib82","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2174\/1389450117666160302094910","article-title":"Targeting cystathionine beta-synthase misfolding in homocystinuria by small ligands: state of the art and future directions","volume":"17","author":"Majtan","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.niox.2022.07.007_bib83","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/164_2017_72","article-title":"Potential pharmacological chaperones for cystathionine beta-synthase-deficient homocystinuria","volume":"245","author":"Majtan","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"37","key":"10.1016\/j.niox.2022.07.007_bib84","doi-asserted-by":"crossref","first-page":"E3845","DOI":"10.1073\/pnas.1414545111","article-title":"Structural insight into the molecular mechanism of allosteric activation of human cystathionine beta-synthase by S-adenosylmethionine","volume":"111","author":"Ereno-Orbea","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"52","key":"10.1016\/j.niox.2022.07.007_bib85","doi-asserted-by":"crossref","first-page":"36018","DOI":"10.1074\/jbc.M114.610782","article-title":"Inter-domain communication of human cystathionine beta-synthase: structural basis of S-adenosyl-L-methionine activation","volume":"289","author":"McCorvie","year":"2014","journal-title":"J. Biol. Chem."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:08:06Z","timestamp":1761070086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860322000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":85,"alternative-id":["S1089860322000830"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2022.07.007","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: Structure-activity relationship and mechanism of action","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2022.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}